Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
| Low |
The actual benefit of the proprietary medicinal product NUCTALON is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. " |
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
UhjncZggAGPCdQ4E
